LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 345 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $326,000 | +9.4% | 2,852 | +20.2% | 0.37% | +6.1% |
| Q1 2019 | $298,000 | -2.3% | 2,372 | +5.5% | 0.34% | -15.6% |
| Q4 2018 | $305,000 | -36.1% | 2,249 | +29.6% | 0.41% | -13.2% |
| Q3 2018 | $477,000 | +13.3% | 1,736 | -14.7% | 0.47% | +24.3% |
| Q2 2018 | $421,000 | -6.9% | 2,034 | -25.7% | 0.38% | -8.0% |
| Q1 2018 | $452,000 | +10.2% | 2,737 | +5.2% | 0.41% | +33.3% |
| Q4 2017 | $410,000 | +8.5% | 2,602 | -0.1% | 0.31% | +7.7% |
| Q3 2017 | $378,000 | +7.7% | 2,604 | -9.9% | 0.29% | +9.1% |
| Q2 2017 | $351,000 | +41.0% | 2,891 | +22.9% | 0.26% | +27.7% |
| Q1 2017 | $249,000 | – | 2,353 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |